Real UK studies, real evidence, real outcomes.

Cerdak required robust clinical evidence and healthcare professional testimonials to support its Drug Tariff submission. Success depended on demonstrating real-world clinical value whilst ensuring the application was supported by credible NHS voices and aligned with wider market access objectives.

Working alongside trusted partners, including Real Healthcare Solutions, NHS healthcare professionals and the Primary Care Research Alliance (PCRA), CRS coordinated clinical evaluations and gathered healthcare professional testimonials that demonstrated patient and clinical benefit. Through our established network and collaborative approach, we were able to rapidly generate high-quality evidence that strengthened the overall submission package.

The resulting evaluations and testimonials clearly highlighted key patient and clinical outcomes and supported Drug Tariff submission activities. By bringing together market access expertise, NHS clinical insight and real-world evidence generation, CRS helped strengthen the evidence base required to support NHS adoption.

“CRS turned around the Cerdak evaluations and testimonials incredibly quickly. The outputs clearly highlighted key patient and clinical outcomes and supported our submission activities.”

Richard Shorney, Founder & Director, Real Healthcare Solutions

Irish medical device company FeelTect was developing an innovative wound care technology and required a partner who could support not only evidence generation, but also the wider journey towards clinical adoption. This included refining the technology, generating real-world evidence, evaluating use within healthcare services, and communicating findings to healthcare audiences and stakeholders.

CRS worked alongside FeelTect throughout multiple stages of product development and commercialisation. We supported clinical evidence generation, facilitated service-based evaluations in preparation for NHS adoption, provided insight to inform product and protocol development, and helped disseminate findings through conference presentations and stakeholder engagement activities. By combining clinical, operational and commercial expertise, we ensured that the evidence generated was both scientifically valuable and commercially relevant.

The project delivered meaningful clinical and commercial insights that informed technology development, protocol refinement and future market strategy. Through rapid recruitment, efficient study delivery and a collaborative approach, FeelTect gained valuable real-world evidence to support ongoing development and route-to-market activities in both the UK and Ireland.

“For a relatively small amount of money, this study has shaped technology improvements, protocol refinements, and elucidated unexpected product benefits that we can hone in on during further development.”

“All members of the team have been responsive to our needs and requests and seem to clearly understand our commercial business needs.”

“I would see this as excellent value for money given the speed of recruitment and the positive outcome.”

Andrew Cameron, FeelTect

Hong Kong-based Cornerstone was developing an innovative surgical robotic system and required clinical evidence to support the next stage of its regulatory and commercial journey. As a pre-market technology without CE marking, the investigation demanded careful management of patient safety, regulatory compliance and clinical governance whilst generating robust safety and efficacy data within an NHS setting.

As Cornerstone's full-service CRO partner, CRS managed all aspects of the clinical investigation. From protocol development and regulatory submissions through to site management, safety oversight, trial coordination and data management, our team worked closely with the sponsor, investigators and NHS site teams to ensure the study was delivered safely and compliantly. With patient safety at the forefront, CRS provided the expertise required to support evaluation of a novel surgical technology in its first use within UK patients.

The study successfully generated valuable safety and efficacy data for a pre-market surgical robotic system, providing the evidence needed to support the technology's ongoing development and future regulatory pathway. Through close collaboration between sponsor, site and CRO, the investigation was delivered to high quality standards whilst maintaining rigorous clinical governance and participant safety throughout.

SolasCure was advancing the clinical development of a novel wound healing therapy and required specialist expertise to support the delivery of a community-based clinical trial in patients with venous leg ulcers. As part of the development programme for an investigational medicinal product, maintaining robust clinical oversight, Good Clinical Practice (GCP) compliance and high-quality trial conduct was essential to generating reliable evidence for future regulatory and commercial milestones.

CRS worked as a trusted extension of the SolasCure team, providing bespoke clinical quality oversight, protocol development support and specialist nursing expertise throughout the study. Our flexible approach allowed us to provide support exactly where it was needed, whether reviewing protocol implementation, supporting study procedures, advising on clinical trial conduct, ensuring GCP compliance or answering questions from the study team. By maintaining close communication and remaining readily available throughout the project, we became a trusted partner that the team could rely upon at every stage of clinical development.

Through expert clinical oversight, specialist wound care knowledge and a collaborative approach, CRS helped maintain high standards of quality throughout the clinical trial. Our involvement supported the generation of robust clinical evidence for an innovative wound healing therapy whilst ensuring the study was delivered in accordance with regulatory and GCP requirements. As SolasCure continues its journey towards regulatory approval and commercialisation, CRS remains a valued partner supporting the delivery of high-quality clinical research.

“I contracted with Clinical Research Solutions to provide clinical quality oversight and nursing support to SolasCure's research team, performing a community based clinical study in Venous Leg Ulcers. Their expertise in community based wound care, combined with flexibility and dedication to the study were instrumental in maintaining the highest standards of clinical quality throughout the trial. I would highly recommend their services for any organization seeking reliable and rigorous clinical support.”

SolasCure

Irish MedTech company EziVein had developed an innovative device designed to support venous access and improve the experience of blood sampling and cannulation. As the product progressed through development, the company needed independent clinical insight to understand how the device would be perceived by healthcare professionals, where it would fit within healthcare pathways and how future evidence-generation activities should be prioritised.

CRS designed and delivered a structured clinician engagement programme, providing access to a broad range of healthcare professionals across multiple clinical settings. Drawing on our networks within the NHS and wider healthcare community, we facilitated meaningful feedback discussions focused on usability, clinical application, workflow integration and future development opportunities.

Importantly, the project went beyond product feedback alone. CRS helped translate clinician perspectives into actionable intelligence, providing strategic insight to support product development, future evidence-generation plans and commercial decision-making. We also identified opportunities for future clinical evaluations and research activities as part of the company's longer-term development strategy.

The programme provided EziVein with valuable independent clinical insight from a diverse range of healthcare professionals. By combining access to frontline clinicians with structured analysis and strategic interpretation, CRS helped the company strengthen its understanding of potential clinical applications, future evidence requirements and next steps on its route towards wider healthcare adoption.